Patient support apparatuses such as hospital beds, stretchers, cots, wheelchairs, and chairs are routinely used by operators to move patients from one location to another. Conventional patient support apparatuses comprise a base and a patient support surface upon which the patient is supported. Wheels are coupled to the base to enable transport over floor surfaces.
A significant number of patient support apparatuses are not powered. However, there is increasing demand to provide patient support apparatuses with energy-consuming devices, such as motors, sensors, and electronics. Conventionally, such energy is provided either by a primary (non-rechargeable) battery or a rechargeable battery.
Patient care increasingly demands more and more attention from caregivers. Any activities that distract the caregiver from the patient are undesirable. One such distracting activity is attending to the battery of the patient support apparatus. For example, primary batteries require frequent replacement. Rechargeable batteries are often low-density and require high maintenance. For example, caregivers often must manually plug a power cord of the patient support apparatus to an electrical outlet (or station) for charging the battery. The power cord is burdensome to manage, thereby consuming more time of the caregiver. Furthermore, the patient support apparatus is generally not available for use when the power cord is plugged into the electrical outlet to charge the battery. Thus, conventional energy systems for patient support apparatuses are undesirable for at least these reasons.
A patient support apparatus with features designed to overcome one or more of the aforementioned challenges is desired.
I. Patient Support Apparatus Overview
Referring to
A support structure 32 provides support for the patient during movement of the patient support apparatus 30. The support structure 32 illustrated in
A mattress 40 is disposed on the patient support deck 38. The mattress 40 comprises a direct patient support surface 43 upon which the patient is supported. The base 34, intermediate frame 36, patient support deck 38, and patient support surfaces 42, 43 each have a head end and a foot end corresponding to the designated placement of the patient's head and feet on the patient support apparatus 30. The construction of the support structure 32 may take on any suitable design, and is not limited to that specifically set forth above or shown in
Side rails 44, 46, 48, 50 are coupled to the intermediate frame 36. A first side rail 44 is positioned at a right head end of the intermediate frame 36. A second side rail 46 is positioned at a right foot end of the intermediate frame 36. A third side rail 48 is positioned at a left head end of the intermediate frame 36. A fourth side rail 50 is positioned at a left foot end of the intermediate frame 36. If the patient support apparatus 30 is a stretcher or a cot, there may be fewer side rails. The side rails 44, 46, 48, 50 are movable between a raised position in which they block ingress and egress into and out of the patient support apparatus 30, one or more intermediate positions, and a lowered position in which they are not an obstacle to enable such ingress and egress. In still other configurations, the patient support apparatus 30 may not include any side rails.
A headboard 52 and a footboard 54 are coupled to the intermediate frame 36. In other embodiments, when the headboard 52 and footboard 54 are included, the headboard 52 and footboard 54 may be coupled to other locations on the patient support apparatus 30, such as the base 34. In still other embodiments, the patient support apparatus 30 does not include the headboard 52 or the footboard 54.
Operator (human control) interfaces 56, such as handles, are shown integrated into the footboard 54 and side rails 44, 46, 48, 50 to facilitate movement of the patient support apparatus 30 over the floor surfaces. Additional operator interfaces 56 may be integrated into the headboard 52 and/or other components of the patient support apparatus 30. The operator interfaces 56 are graspable by the operator to manipulate the patient support apparatus 30 for movement. The operator interface 56 may comprise one or more handles coupled to the intermediate frame 36. The operator interface 56 may simply be a surface on the patient support apparatus 30 upon which the operator locally applies force to cause movement of the patient support apparatus 30 in one or more directions, also referred to as a push location. This may comprise one or more surfaces on the intermediate frame 36 or base 34. This could also comprise one or more surfaces on or adjacent to the headboard 52, footboard 54, and/or side rails 44, 46, 48, 50. In other embodiments, the operator interface 56 may comprise separate handles for each hand of the operator. For example, the operator interface 56 may comprise two handles. Other forms of the operator interface 56 are also contemplated.
One or more caster assemblies 58 are coupled to the base 34 to facilitate transport over floor surfaces. In one example, as shown in
The patient support apparatus 30 may comprise any suitable number of caster assemblies 58, such as two or six, etc. The caster assemblies 58 may have any suitable configuration and arrangement depending on the specific type of patient support apparatus 30. For example, when the patient support apparatus 30 is a wheelchair, the patient support apparatus 30 may comprise two front non-driven caster assemblies 58 and two rear driven caster assemblies 58.
Additionally, one or more auxiliary wheels 66 (powered or non-powered), which may be movable between stowed positions and deployed positions, may be coupled to the support structure 32. In some cases, when these auxiliary wheels 66 are located between the caster assemblies 58 and contact the floor surface in the deployed position, they cause two of the caster assemblies 58 to be lifted off the floor surface thereby shortening a wheel base of the patient support apparatus 30. Such auxiliary wheels 66 may also be arranged substantially in a center of the base 34.
The patient support apparatus 30 comprises a controller 68 in communication with and for controlling any suitable components of the patient support apparatus 30, such as the electrical or electromechanical components described herein. The controller 68 may comprise any suitable signal processing means, computer executable instructions or software modules stored in non-transitory memory wherein the executable instructions or modules may be executed by a processor, or the like. Additionally, or alternatively, the controller 68 may comprise a microcontroller, a processor, one or more integrated circuits, logic parts, and the like for enabling the same. The controller 68 may have any suitable configuration for enabling performance of various tasks related to operation of the patient support apparatus 30, such as those described below. The controller 68 may be located at any suitable location of the patient support apparatus 30.
Referring to
For example, the electrical device 70 may be an actuator 74, such as a motor, for moving the patient support deck 38 in different positions and/or for lifting the intermediate frame 36. The actuator 74 may also be coupled to one or more of the wheels 58, 66 for steering or drive purposes. Additionally, the actuator 74 may be provided for a “pre-swivel” mechanism or a “steer-lock” mechanism. In another example, the electrical device 70 is an electronic scale 76 for detecting patient weight and/or patient presence.
The electrical device 70 may be a user interface (UI) device 78 provided for communicating with the operator and/or accepting user input to enable the operator to control aspects of the patient transport apparatus 30. The user interface device 78 may comprise a digital display (e.g., backlit display), buttons, touch-screens, voice activation, or combinations thereof. The user interface device 78 may be mounted to the headboard 52, footboard 54, side rails 44, 46, 48, 50, or any other suitable location on the patient transport apparatus 30. The user interface device 78 may also be removably attached to or located remotely from the patient transport apparatus 30. The user interface device 78 may have any other suitable configuration for communicating with the operator and/or accepting user input to enable the operator to control aspects of the patient transport apparatus 30.
In other examples, the electrical device 70 is a communication unit or device 80 for enabling communication with other components of the patient transport apparatus 30 and/or to enable the patient transport apparatus 30 to communicate with external communication sources. The communication device 80 may be wireless or wired. Examples of such communication devices 80 include, but are not limited to, transmitters, mobile RF communication devices, receivers, transponders, transceivers, near-field communication devices, antennae, low power IEEE 802.15.1 enabled devices, infrared devices, wireless access points, Wi-Fi devices or modules, and the like. The communication device 80 may have any other suitable configuration for implementing those functions described herein, and those not specifically recited herein.
The electrical device 70 may be any electronic sensor 82 employed by the patient transport apparatus 30, including, but not limited to, force sensors (e.g., sensors for any of the headboard 52, footboard 54, and/or side rails 44, 46, 48, 50), steering sensors, brake sensors, speed sensors, position sensors, electronic accelerometers, electronic gyroscopic sensors, potentiometers, strain gauges, capacitive sensors, piezoresistive sensors, proximity sensors (e.g., Hall effect sensors), piezoelectric sensors, GPS sensors, IR sensors, RF sensors, electromagnetic sensors, and combinations thereof. Moreover, the electrical device 70 may be the controller 68 itself.
As shown in
The electrical distribution system 84 may be routed throughout various components of the patient support apparatus 30, such as the support structure, 32, base 34, intermediate frame 36, and/or patient support deck 38. The electrical distribution system 84 may have any configuration desired for adequately distributing power, or enabling control of power delivery, to any of the electrical devices 70.
The ESD 72 is coupled to the electrical distribution system 84. The stored energy in the ESD 72 is distributed to any of the electrical devices 70 through the electrical distribution system 84. The ESD 72, according to one embodiment, exhibits a high or ultra-high energy density. Energy density is the amount of energy stored in per unit volume of the ESD 72. In one example, the energy density is in a range between 1-30 MJ/L.
The ESD 72 may be specifically configured for use with a wireless power transfer (WPT) systems employed by the patient support apparatus 30. With a WPT system, a peak power draw is taken into account wherein the WPT system would require peak current draw above a certain current threshold, e.g., above 10 Amps. High-density ESDs 72, such as the supercapacitors, are capable of storing power for such peak current draw required by the WPT system. When power is needed for the patient support apparatus 30, the high-density ESD 72 can deliver large amounts of power quickly and efficiently with little loss of energy during transfer. The high-density ESD 72 exhibits a long life allowing for hundreds of thousand charging and discharge cycles. Conventional batteries, on the other hand, are bulky and have charge discharge cycles in the five hundred cycle range, or less. In turn, the high-density ESD 72 reduces the overall power transfer required under wireless device use to less than one amp and reduces the need for larger and more expensive battery components and circuitry. Furthermore, the overall energy delivery system of the patient support apparatus 30 is reduced in physical size and the overall cost of the energy delivery system is reduced. Additionally, the ESD 72 often obtains charge originally from the electrical system of the facility in which the patient support apparatus 30 is located. By utilizing such high-density ESDs 72, the overall facility power consumed by the patient support apparatuses 30 in the facility is reduced, in turn, allowing the electrical system of the facility to be less burdened.
The ESD 72 may be designed electrochemically or chemically. In one example, the ESD 72 is a battery. The battery may be a Lithium-ion battery. The Lithium-ion battery may be one or more of a Lithium Cobalt Oxide, Lithium Manganese Oxide, Lithium Iron Phosphate, Lithium Nickel Manganese Cobalt Oxide, Lithium Nickel Cobalt Aluminum Oxide, and Lithium Titanate battery. In other examples, the ESD 72 is a Lithium battery, a Lead-acid battery, or a Nickel-metal hydride battery.
In other examples, the ESD 72 is not a battery, but rather a supercapacitor. The supercapacitor may be electrical or electrostatically based, such as an electric double-layer capacitor (EDLC). In another example, the supercapacitor is a pseudo-capacitor or a hybrid capacitor.
The patient support apparatus 30 may comprise any number of ESDs 72 of the same type. In some embodiments, a second ESD 86, which is of a different type as compared with the first ESD 72. The second ESD 86 is coupled to the electrical distribution system 84. The stored energy in the second ESD 72 may also be distributed to any of the electrical devices 70 through the electrical distribution system 84. Additional techniques involving management of the first and second ESDs 72, 86 are provided below.
The controller 68 may be coupled to the electrical distribution system 84 for controlling power distribution operations. Specifically, the electrical distribution system 84 may comprise one or more control blocks 88a-88b for controlling power distribution. Any of the control blocks 88a-88b described herein may be disposed on a device separate from the controller 68 or may be integrated within the controller 68 itself. In either scenario, the controller 68 can provide selective control over the control blocks 88a-88b, for purposes such as enabling or disabling power distribution through certain pathways. The control blocks 88a-88b may comprise any suitable switches (e.g., transistors), integrated circuits, and other electrical components for enabling power distribution control. Additionally, or alternatively, the control block 100 may be a software block or module.
In
II. ESD Swapping
Techniques are described herein, which provide seamless ESD 72 management, thereby requiring less attention from caregivers for maintenance of the ESD 72. In other words, distraction of the caregiver in attending to the replacing or charging an ESD 72 is reduced, allowing more time for the caregiver to attend to patient care, or other important matters. The techniques described herein further reduce the need to provide the patient support apparatus 30 with a burdensome power cord for charging the ESD 72. As will be appreciated from the examples below, caregivers no longer need to manually plug a power cord to an electrical outlet (or station) for charging the ESD 72. Furthermore, with the ESD 72 management techniques described herein, the patient support apparatus 30 can remain available for use for longer periods.
The patient support apparatus 30 provides means for enabling swapping or easy replacement of the ESD 72 or any number of ESDs 72. Such swapping may be needed to replace the ESD 72 when the ESD is low on charge or life. Swapping may also be useful to maintain the overall charge level among a plurality of ESDs 72 above a certain threshold. The ESD 72 is provided on the patient support apparatus 30 in a plug-and-play manner.
To enable such swapping, the patient support apparatus 30, as shown in
The receptacle 100 is coupled to any suitable location on the patient support apparatus 30 that enables the ESD 72 to be readily accessible. In one example, as shown in
Referring to one example, in
The slot 104 may be any suitable size for receiving the casing 102. In one example, the slot 104 conforms to the casing 102 such that ESD 72 is secured from movement when installed in the receptacle 100. In one embodiment, the slot 104 is defined such that the casing 102 substantially occupies the slot 102 when the receptacle 100 receives the ESD 72. Alternatively, the casing 102 may occupy a portion of the slot 102 such that other portions of the casing 102 are outside of the receptacle 100.
As shown in
The receptacle 100 has electrical contacts 108 configured to interface with the electrical contacts 106 of the ESD 72. The electrical contacts 106, 108 couple when the receptacle 100 receives the ESD 72. In one embodiment, the electrical contacts 108 of the receptacle 100 conform to the electrical contacts 106 of the ESD 72. For example, in
The electrical contacts 108 of the receptacle 100 are coupled to the electrical distribution system 84 of the patient support apparatus 30. As such, when the ESD 72 is fully engaged with the receptacle 100, and the electrical contacts 106, 108 interface with one another, the ESD 72 becomes coupled to the electrical distribution system 84. From here, the ESD 72 can be discharged through the receptacle 100 to power the one or more electrical devices 70 through the electrical distribution system 84. Additionally or alternatively, the ESD 72 can be charged through the receptacle 100 to increase energy stored therein.
Furthermore, the controller 68 may be coupled to the electrical contacts 108 of the receptacle 100 for actively controlling operation of the ESD 72 when installed in the receptacle 100. For example, the controller 68 may selectively disconnect the electrical contacts 108 of the receptacle 100 from the electrical distribution system 84 using switches 110 to prevent the ESD 72 from powering the one or more electrical devices 70, and vice-versa
To further enable easy swapping of the ESD 72 to and/or from the patient support apparatus 30, the ESD 72 comprises a first interface 112 configured to allow easy handling of the ESD 72. The first interface 112 is configured to be physically engaged for removal of the ESD 72 from the receptacle 100 and/and for insertion of the ESD 72 into the receptacle 100.
The first interface 112 is coupled to the casing 102 and may be mechanically attached to the casing 102 or integrated with the casing 102. The first interface 112 is configured to structurally support the weight of the ESD 72 when the ESD 72 is physically engaged by the first interface 112. As shown in
The first interface 112 located in any suitable location on the ESD 72 depending on the shape of the ESD 72 and/or the shape of the receptacle 100. In one example, the first interface 112 is located such that when the ESD 72 is disposed in the receptacle 100, the first interface 112 remains exposed to allow accessibility for physically engagement. The first interface 112 may have any other suitable configuration for enabling swapping of the ESD 72 to and/or from the patient support apparatus 30. Furthermore, any number of first interfaces 112 may be utilized for the ESD 72, and may be of a common or different configuration from one another.
As will be appreciated from the examples below, the patient support apparatus 30 may utilize an ESD 72b that was initially located remote from the patient support apparatus 30 and later provided on the patient support apparatus 30 to supplement and/or to replace existing ESDs 72. For simplicity, ESDs 72b of this nature are referred to as replacements ESDs 72b below. It should be appreciated that the replacements ESD 72b may be the same or different type as existing ESDs 72a on the patient support apparatus 30. Furthermore, any of the existing ESDs 72a on the patient support apparatus 30 may have formally been a replacement ESD 72b, i.e., before being installed on the patient support apparatus 30. Any of the features, structure, and/or functions of the ESD 72a may be applied fully to any replacement ESD 72b described herein.
With the understanding of the patient support apparatus 30, as described, a system 120 is provided that includes the patient support apparatus 30 in conjunction with a unit 122 that is independent from the patient support apparatus 30. The unit 122 is configured to interact autonomously with the patient support apparatus 30. Specifically, the unit 122 is configured to autonomously remove the ESD 72a from the patient support apparatus 30 and/or to autonomously place the replacement ESD 72b on to the patient support apparatus 30. The unit 122 may also be understood as a swapping unit or an ESD swapper.
As will be appreciated from the examples below, the autonomous nature of the unit 122 may be understood as being fully or semi-autonomous. When fully autonomous, the caregiver need not perform any preliminary tasks to enable the unit 122 to perform autonomous swapping. In other words, the unit 122 is configured to approach the patient support apparatus 30 autonomously and perform autonomous swapping, even if, for example, the caregiver is not near the patient support apparatus 30. When semi-autonomous, the caregiver may need to perform some preliminary tasks to enable the unit 122 to perform autonomous swapping. For example, such preliminary tasks may include activating the unit 122, signaling to the unit 122 that swapping is desired, and/or moving the patient support apparatus 30 to a location suitable for the unit 122 to perform autonomous swapping. However, with semi-autonomous swapping, the unit 122, and not the caregiver, removes the ESD 72a from the patient support apparatus 30 and/or to places the replacement ESD 72b on to the patient support apparatus 30.
As will be understood from the embodiments herein, the unit 122 may be of various configurations. For example, in the embodiment of
The unit 122 is configured to physically engage the ESD 72 to enable autonomous removal or installing of the same. In one example, the unit 122 may physically engage the casing 102 of the ESD 72 without regard to the first interface 112. For instance, the unit 122 may slide a mechanism below, or around, the ESD 72 for sliding the ESD 72 into and out of the patient support apparatus 30.
In another example, the unit 122 may engage the ESD 72 by physically engaging the first interface 112 of the ESD 72. In such configurations, the unit 122 may comprise a second interface 130 configured to physically engage the first interface 112. The first and second interfaces 112, 130 may be mechanical interfaces that are configured to mechanically interlock. In other examples, the first and second interfaces 112, 130 may be magnetic, electromagnetic, or the like.
In one embodiment, the second interface 130 is embodied as a static mechanical member. For example, as shown in
In
In another embodiment, the second interface 130 is embodied as a gripping device. For example, as shown in
In
In yet another embodiment, the second interface 130 is embodied as a connector. For example, as shown in
In
The second interface 130 of the unit 122 may physically engage the first interface 112 of the ESD 72 according to examples other than those shown in
The unit 122 comprises a controller 132 in communication with and for controlling any suitable components of the unit 122, such as the electrical or electromechanical components described herein. The controller 132 may comprise any suitable signal processing means, computer executable instructions or software modules stored in non-transitory memory wherein the executable instructions or modules may be executed by a processor, or the like. Additionally, or alternatively, the controller 132 may comprise a microcontroller, a processor, one or more integrated circuits, logic parts, and the like for enabling the same. The controller 132 may have any suitable configuration for enabling performance of various tasks related to operation of the unit 122 such as those described below. The controller 132 may be located at any suitable location of the unit 122. Additional functionality of the controller 132 will be understood from the various embodiments described herein.
The unit 122 may also comprise and/or interact with a charging station 134. The charging station 134 is configured to charge replacement ESDs 72b. The charging station 134 may be coupled to the controller 132 such that the controller 132 can monitor and control charge delivered to the replacements ESDs 72b. The charging station 134 may be integrated with the unit 122 or coupled thereto. In other embodiments, the charging station 134 is remote from the unit 122, but the unit 122 may be configured to autonomously locate and deposit and/or remove ESDs to/from the charging station 134. For example, the charging station 134 may be coupled to a wall or a floor surface of the facility and many charging stations 134 may be located throughout the facility.
In one example, the charging station 134 comprises a receptacle 136 for housing the replacement ESD 72b. The unit 122 is configured to autonomously place the ESDs 72a into the receptacle and/or to autonomously remove the replacement ESD 72b from the receptacle. The receptacle 136 of the charging station 134 comprises electrical contacts 138 coupled to a power source. The electrical contacts 138 of the charging station 134 interface with the electrical contacts 106 of the replacement ESD 72b to enable the power source to electrically charge the same.
The receptacle 136 of the charging station 134 may have a configuration or functionality according to any of the configurations or functionally of the receptacle 100 of the patient support apparatus 30. The configurations of receptacle 100 apply fully to receptacle 136, and therefore, are not repeated herein for simplicity.
Referring now to
The unit 122, and specifically the robotic device 124, may be coupled to, or may include, a tracking system 144 that is configured to track the position and orientation of the patient support apparatus 30 relative to the unit 122. In the example of
In
In
In
In
In
The robotic device 124, charging station 134, and tracking system 144 may have configurations other than those shown in
Referring now to
In
In this example, the receptacle 100 of the patient support apparatus 30 has one vacancy for placement of the replacement ESD 72b. The other ESD 72a in the receptacle 100 is low on energy and should be removed. Of course, situations for the ESDs 72 other than those shown in the Figures may be fully addressed by the techniques described herein.
In
In
In the embodiment of
A docking feature 162 enables the patient support apparatus 30 to be captured by the docking station 128. The docking feature 162 may be integrated with or attached to the docking system 128 or may be separated therefrom. The docking feature 162 may be a passive object or an actively energized device. As shown in
The docking system 128 further comprises a machine 164 for physically moving the ESDs 72. The machine 164 in this embodiment comprises a rail unit 166, which moves along or by guide tracks 168. The guide track 168 may be fixed to the housing 160 and/or or coupled to the rail unit 166 such that the rail unit 166 is moved through extension of the guide track 168. The rail unit 166 and/or the guide tracks 168 may comprise motors to enable such movement. The second interface 130 is coupled to the rail unit 166. The docking system 128 in this example is semi-autonomous, thereby requiring the caregiver to dock the patient support apparatus 30 before autonomous management of the ESDs 72 is carried out.
In
In
In
In
Knowing that the replacement ESD 72b is needed in this example, and knowing the location of the replacement ESD 72b in the housing 160, the docking system 128, in
In
Finally, in
The docking system 128 may have configurations other than those shown in
III. Communication System and Software Program
Referring now to
A mobile computing device 208 that is independent of the patient support apparatus 30 may be provided. The mobile computing device 208 may convey information about the patient support apparatus 30 and/or the unit 122. The mobile computing device 208 may be carried by an individual in the facility who may interacts with the patient support apparatus 30 and/or the unit 122. Examples of such individuals include, but are not limited to, caregivers, other healthcare personnel, facility maintenance personnel, patients, and the like. The mobile computing device 208 may be any suitable device, such as a tablet or smart phone, etc. The mobile computing device 208 may have access to a map of the facility through an updatable software application. Additionally, application programming interfaces (APIs) may be utilized to retrieve map information. The mobile computing device 208 may be equipped with its own display device, sensors, and communication unit, which may be like those described herein.
A server 210 is configured to receive the readings of the sensors 82, 202 over one or more networks 212a, 212b. The server 210 is configured to analyze the readings, and to respond to any of the communication units 80, 206. For example, the server 210 may receive readings from sensors 82 of the patient support apparatus 30 and, in response, communicate information to the unit 122, to the mobile computing device 208, or any combination thereof. The server 210 may be configured to analyze the readings using a navigation module 214 and receive readings and/or transit information and/or using a communication module 216.
The navigation module 214 is provided for location services for the patient support apparatus 30, the unit 122, and/or the mobile computing device 208. The navigation module 214 may include sub-modules, such as an analysis sub-module configured to analyze the readings from the sensors 82, 202, a map module configured to determine a map of the facility and to determine the position and/or orientation of the patient support apparatus 30, the unit 122, and/or the mobile computing device 208 relative to the facility map.
Access points 218 are configured to be disposed throughout the facility and are configured to receive the readings from the patient transport apparatus 30, the unit 112, and/or the mobile computing device 208, e.g., over the network 212a, and to send the readings to the server 210, e.g., over the network 212b. The communication system 200 may have configurations or functionality other than that described herein.
A non-transitory computer-readable medium 220a-220c, or memory, may be provided on the patient support apparatus 30, the unit 122, the mobile computing device 208, and/or the server 210. The memory 220 may store instructions, which implement a software program. Thus, the software program may exist on the memory 220 of any one or more of the patient support apparatus 30, the unit 122, the mobile computing device 208, and/or the server 210. The software program comprises instructions, which when executed by one or more processors, are configured to provide information presentable on one of the display devices 78, 204 relating to interaction between the patient support apparatus 30 and the unit 122. The software program may be configured to track a location of the patient support apparatus 30 and a location of the unit 122 in the facility, e.g., using the communication system 200.
The software program enhances the ESD 72 swapping techniques described above. The software program gives the user of the patient support apparatus 30 sophisticated insight into information relating to the ESD 72, and swapping thereof, that would otherwise be unavailable to or unobtainable by the user.
One example of a graphical user interface (GUI) 230 produced by the software program is shown in
The software program is configured to display a notification 234 regarding a status of the ESD 72a used by the patient support apparatus 30. The notification 234, for example, may convey information indicative of needed removal of the ESD 72a and/or needed placement of the replacement ESD 72b using the unit 122. In
The notification 234 may also display a proximity between the patient support apparatus 30 and the unit 122 according to time and/or distance. For example, as shown in
The software program may further enable the GUI 230 to display navigation information to help the patient support apparatus 30 reach the unit 122. For instance, the GUI 230 may display a projected and optimized route 238 on the map 232 that the patient support apparatus 30 should travel to reach the unit 122 in the projected time. The GUI 230 may also display directions 240 specifically computed to help the patient support apparatus 30 follow the route 238. In
The software program may also convey information relating to actions performed by the unit 122 relative to the patient support apparatus 30. For example, the GUI 230 may display a notification conveying any one or more of the following: removal of the ESD 72a by the unit 122, installation of the replacement ESD 72b by the unit 122, a docking or communication linking status between the patient support apparatus 30 and the unit 122, and the like. The software program may convey information relating to the unit 122 other than those described herein.
Furthermore, in additional embodiments, the server 210 may enable the software program to provide notifications to the display devices 78, 204 regarding service notifications for any of the ESDs 72, 86. The server 210 may be provided with predictive maintenance algorithms that can keep track of usage, and anticipated service life of any of the ESDs 72, 86. The notifications can be triggered in response to the ESD 72 being swapped a specific number of times, for instance, or based on the overall time the ESD 72 has been utilized during its lifetime. The ESDs 72 may be equipped with sensors or communication devices for sending data for service or tracking purposes. Such data may be sent using the communication device 80 of the patient support apparatus 30, for example. The status of the ESDs 72 can be communicated to the server 210 such that the server 210 can keep a running log of the usage and location of the ESDs 72. In some embodiments, the software program notifies the user about the quantity of available ESDs 72. For instance, the notification may convey how many replacement ESDs 72b are available at each unit 122. In another example, the notification conveys where in the facility ESDs 72 are in low or high supply. For example, when in short supply in a region of the facility, the notification can be sent to promote the user to utilize certain units 122 in that region of the facility and to let the unit 122 retrieve ESDs 72 from the patient support apparatus 30 to increase supply in the region. Service related features may be provided by the server 210 and/or software program other than those described herein.
IV. ESD Control Techniques
As described in relation to
In one technique, control block 88a implements a constant charging circuit. The charging circuit regulates charging of the ESD 72. This circuit prevents the electrical distribution system 84, or any of the electrical devices 70, from drawing excessive current or voltage from the facility power supply when the patient support apparatus 30, is first turned on. This helps prevent the high-density ESD 72 from overheating. The charging circuit regulates charge provided to the ESDs 72 such that the provided current or voltage is relatively uniform. For constant current, the circuit may comprise an integrated circuit that varies voltage applied to the ESD 72 to maintain a constant current flow. For constant voltage, the circuit may comprise a step down transformer with a rectifier to provide the DC voltage to charge the ESDs 72. Other charging control schemes, such as trickle charging, pulsed charging, and other slow or fast charging schemes may be utilized.
In another technique, charge supplied to, and/or charge supplied from the ESD 72 and second ESD 86 is regulated by the controller 68 in tandem. As mentioned, the second ESD 86 is of a different type as compared with the first ESD 72. Although the term “second” is used to describe the second ESD 86, the second ESD 86 may be the primary energy supply for the patient transport apparatus 30 while the ESD 72 is a back-up energy supply. On the other hand, the ESD 72 may be the primary energy supply while the second ESD 86 is a back-up supply of energy.
It may be desirable for the patient support apparatus to rely on both the ESD 72 and the second ESD 86 for power, in some examples. However, it may also be desirable to rely only on one of the ESD 72 and second ESD 86 for power, and not both at the same time.
To manage the aforementioned scenarios, the controller 68 may include an ESD module 300, as shown in
The ESD module 300 may make such determinations depending a plurality of factors, such as a measured self-discharge of the ESD 72 or second ESD 86, the inherent charging/discharging properties of the high-density ESD 72 as compared with the second ESD 86, a storage capacity of the ESD 72 or second ESD 86, a current charge level of the ESD 72 or second ESD 86, and the like. Another factor used in determinations made by the ESD module 300 may include characteristics of the power demanded by the electrical devices 70, as determined by the controller 68. For example, the ESD module 300 may tap energy from the high-density ESD 72 to satisfy a sudden spike in demanded power, knowing that the charge level of the ESD 72 would otherwise be lost from inherent self-discharge. Any other factors may be utilized in making such energy management determinations.
To execute such control, the controller 68 can selectively disconnect one of the ESDs 72, 86 from the electrical distribution system 84, using, for example, the control block 88a. In response to selectively disconnecting one of the ESDs 72, 86, the controller 68 can selectively connect, or otherwise confirm connection of, the other one of the ESDs 72, 86 to the electrical distribution system 84 to power the one or more electrical devices 70 instead of the disconnected ESD 72, 86. Control schemes for managing the ESDs 72, 86 may have configurations other than those shown and described herein.
It will be further appreciated that the terms “include,” “includes,” and “including” have the same meaning as the terms “comprise,” “comprises,” and “comprising.”
Several embodiments have been discussed in the foregoing description. However, the embodiments discussed herein are not intended to be exhaustive or limit the invention to any particular form. The terminology which has been used is intended to be in the nature of words of description rather than of limitation. Many modifications and variations are possible in light of the above teachings and the invention may be practiced otherwise than as specifically described.
The subject patent application claims priority to and all the benefits of U.S. Provisional Patent Application No. 62/576,318 filed on Oct. 24, 2017, the disclosure of which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3644945 | Goodman et al. | Feb 1972 | A |
3743905 | Goodman et al. | Jul 1973 | A |
3763979 | Goodman et al. | Oct 1973 | A |
4095822 | Thornhill | Jun 1978 | A |
4944056 | Schroeder et al. | Jul 1990 | A |
4961422 | Marchosky et al. | Oct 1990 | A |
5164623 | Shkondin | Nov 1992 | A |
5197466 | Marchosky et al. | Mar 1993 | A |
5591217 | Barreras | Jan 1997 | A |
5697110 | Campbell | Dec 1997 | A |
5708993 | Campbell et al. | Jan 1998 | A |
5769877 | Barreras, Sr. | Jun 1998 | A |
5806110 | Kunz et al. | Sep 1998 | A |
5806111 | Heimbrock et al. | Sep 1998 | A |
5807397 | Barreras | Sep 1998 | A |
5821728 | Schwind | Oct 1998 | A |
5991665 | Wang et al. | Nov 1999 | A |
6460828 | Gersemsky et al. | Oct 2002 | B1 |
6532607 | Heil | Mar 2003 | B1 |
6802385 | Pyntikov et al. | Oct 2004 | B2 |
6838174 | Nakahigashi | Jan 2005 | B2 |
6870475 | Fitch et al. | Mar 2005 | B2 |
6871714 | Johnson | Mar 2005 | B2 |
6896468 | Gallea | May 2005 | B2 |
6966083 | Cheng | Nov 2005 | B1 |
7010369 | Borders et al. | Mar 2006 | B2 |
7154397 | Zerhusen et al. | Dec 2006 | B2 |
7256705 | Kagermeier et al. | Aug 2007 | B2 |
7321811 | Rawls-Meehan | Jan 2008 | B1 |
7398571 | Souke et al. | Jul 2008 | B2 |
7404221 | Sackner | Jul 2008 | B2 |
7465280 | Rawls-Meehan | Dec 2008 | B2 |
7528521 | Naitou et al. | May 2009 | B2 |
7530616 | Pomper | May 2009 | B2 |
7650192 | Wahlstrand | Jan 2010 | B2 |
7679520 | Zerhusen et al. | Mar 2010 | B2 |
7725968 | Lambarth | Jun 2010 | B2 |
7825544 | Jansen et al. | Nov 2010 | B2 |
7868740 | McNeely et al. | Jan 2011 | B2 |
7887113 | Lambarth et al. | Feb 2011 | B2 |
7911349 | Zerhusen et al. | Mar 2011 | B2 |
8000800 | Takeda et al. | Aug 2011 | B2 |
8006332 | Lemire et al. | Aug 2011 | B2 |
8019486 | Rawls-Meehan | Sep 2011 | B2 |
8031057 | McNeely et al. | Oct 2011 | B2 |
8032263 | Rawls-Meehan | Oct 2011 | B2 |
8035255 | Kurs et al. | Oct 2011 | B2 |
8046115 | Rawls-Meehan | Oct 2011 | B2 |
8046116 | Rawls-Meehan | Oct 2011 | B2 |
8046117 | Rawls-Meehan | Oct 2011 | B2 |
8056163 | Lemire et al. | Nov 2011 | B2 |
8056950 | Souke et al. | Nov 2011 | B2 |
8063785 | Sacchetti | Nov 2011 | B2 |
8069512 | Rawls-Meehan | Dec 2011 | B2 |
8078336 | Rawls-Meehan | Dec 2011 | B2 |
8078337 | Rawls-Meehan | Dec 2011 | B2 |
8106539 | Schatz et al. | Jan 2012 | B2 |
8121856 | Huster et al. | Feb 2012 | B2 |
8125318 | Heimbrock et al. | Feb 2012 | B2 |
8129865 | Krumme et al. | Mar 2012 | B2 |
8143846 | Herman et al. | Mar 2012 | B2 |
8177274 | Pomper | May 2012 | B2 |
8285388 | Wahlstrand | Oct 2012 | B2 |
8295940 | Sherman | Oct 2012 | B2 |
8304935 | Karalis et al. | Nov 2012 | B2 |
8324759 | Karalis et al. | Dec 2012 | B2 |
8334779 | Zerhusen et al. | Dec 2012 | B2 |
8344860 | Collins, Jr. et al. | Jan 2013 | B2 |
8362742 | Kallmyer | Jan 2013 | B2 |
8368545 | Zerhusen et al. | Feb 2013 | B2 |
8375488 | Rawls-Meehan | Feb 2013 | B2 |
8400017 | Kurs et al. | Mar 2013 | B2 |
8400104 | Adamczyk et al. | Mar 2013 | B2 |
8410636 | Kurs et al. | Apr 2013 | B2 |
8439416 | Lambarth et al. | May 2013 | B2 |
8441154 | Karalis et al. | May 2013 | B2 |
8447366 | Ungari et al. | May 2013 | B2 |
8461719 | Kesler et al. | Jun 2013 | B2 |
8461720 | Kurs et al. | Jun 2013 | B2 |
8461721 | Karalis et al. | Jun 2013 | B2 |
8461722 | Kurs et al. | Jun 2013 | B2 |
8466583 | Karalis et al. | Jun 2013 | B2 |
8471410 | Karalis et al. | Jun 2013 | B2 |
8476788 | Karalis et al. | Jul 2013 | B2 |
8482158 | Kurs et al. | Jul 2013 | B2 |
8487480 | Kesler et al. | Jul 2013 | B1 |
8497601 | Hall et al. | Jul 2013 | B2 |
8499384 | Zerhusen | Aug 2013 | B2 |
8536990 | Collins, Jr. et al. | Sep 2013 | B2 |
8551163 | Aber et al. | Oct 2013 | B2 |
8554322 | Olson et al. | Oct 2013 | B2 |
8565934 | Rawls-Meehan | Oct 2013 | B2 |
8569914 | Karalis et al. | Oct 2013 | B2 |
8587153 | Schatz et al. | Nov 2013 | B2 |
8587155 | Giler et al. | Nov 2013 | B2 |
8604916 | McNeely et al. | Dec 2013 | B2 |
8604917 | Collins et al. | Dec 2013 | B2 |
8606344 | DiMaio et al. | Dec 2013 | B2 |
8618696 | Kurs et al. | Dec 2013 | B2 |
8626249 | Ungari et al. | Jan 2014 | B2 |
8629578 | Kurs et al. | Jan 2014 | B2 |
8634981 | Hyde et al. | Jan 2014 | B1 |
8641629 | Kurokawa | Feb 2014 | B2 |
8669676 | Karalis et al. | Mar 2014 | B2 |
8674839 | Zerhusen et al. | Mar 2014 | B2 |
8686598 | Schatz et al. | Apr 2014 | B2 |
8692410 | Schatz et al. | Apr 2014 | B2 |
8716903 | Kurs et al. | May 2014 | B2 |
8723366 | Fiorello et al. | May 2014 | B2 |
8725262 | Olson et al. | May 2014 | B2 |
8729737 | Schatz et al. | May 2014 | B2 |
8764621 | Badstibner et al. | Jul 2014 | B2 |
8772973 | Kurs | Jul 2014 | B2 |
8782826 | White et al. | Jul 2014 | B2 |
8799011 | Wilson et al. | Aug 2014 | B2 |
8847548 | Kesler et al. | Sep 2014 | B2 |
8862241 | Forsell | Oct 2014 | B2 |
8864205 | Lemire et al. | Oct 2014 | B2 |
8866598 | Collins, Jr. et al. | Oct 2014 | B2 |
8869328 | Rawls-Meehan | Oct 2014 | B2 |
8886333 | Lui et al. | Nov 2014 | B2 |
8886383 | Hyde et al. | Nov 2014 | B2 |
8887619 | Kallmyer et al. | Nov 2014 | B2 |
8890470 | Partovi | Nov 2014 | B2 |
8896264 | Partovi | Nov 2014 | B2 |
8901778 | Kesler et al. | Dec 2014 | B2 |
8901779 | Kesler et al. | Dec 2014 | B2 |
8901881 | Partovi | Dec 2014 | B2 |
8907531 | Hall et al. | Dec 2014 | B2 |
8909378 | Rawls-Meehan | Dec 2014 | B2 |
8912687 | Kesler et al. | Dec 2014 | B2 |
8917166 | Collins, Jr. et al. | Dec 2014 | B2 |
8928276 | Kesler et al. | Jan 2015 | B2 |
8933594 | Kurs et al. | Jan 2015 | B2 |
8937408 | Ganem et al. | Jan 2015 | B2 |
8946938 | Kesler et al. | Feb 2015 | B2 |
8963488 | Campanella et al. | Feb 2015 | B2 |
8973963 | Lambarth et al. | Mar 2015 | B2 |
8984685 | Robertson et al. | Mar 2015 | B2 |
9002469 | D'Ambrosio | Apr 2015 | B2 |
9038218 | Heil et al. | May 2015 | B1 |
9044365 | Rawls-Meehan | Jun 2015 | B2 |
9044366 | Rawls-Meehan | Jun 2015 | B2 |
9050031 | Collins, Jr. et al. | Jun 2015 | B2 |
9052718 | Hyde et al. | Jun 2015 | B2 |
9059599 | Won et al. | Jun 2015 | B2 |
9079043 | Stark et al. | Jul 2015 | B2 |
9089462 | Lafleche | Jul 2015 | B1 |
9093853 | Schatz et al. | Jul 2015 | B2 |
9101521 | White et al. | Aug 2015 | B2 |
9105959 | Kesler et al. | Aug 2015 | B2 |
9106203 | Kesler et al. | Aug 2015 | B2 |
9107783 | Childs et al. | Aug 2015 | B2 |
9108063 | Olson et al. | Aug 2015 | B2 |
9114050 | White et al. | Aug 2015 | B2 |
9125779 | Hyde et al. | Sep 2015 | B2 |
9132051 | Heil | Sep 2015 | B2 |
9139310 | Wang | Sep 2015 | B1 |
9149126 | Rawls-Meehan | Oct 2015 | B2 |
9160203 | Fiorello et al. | Oct 2015 | B2 |
9161633 | Rawls-Meehan | Oct 2015 | B2 |
9173793 | Rawls-Meehan | Nov 2015 | B2 |
9173794 | Rawls-Meehan | Nov 2015 | B2 |
9182750 | Rawls-Meehan | Nov 2015 | B2 |
9184595 | Kurs et al. | Nov 2015 | B2 |
9218454 | Kiani et al. | Dec 2015 | B2 |
9220651 | Hyde et al. | Dec 2015 | B2 |
9233039 | Hyde et al. | Jan 2016 | B2 |
9237814 | Rawls-Meehan | Jan 2016 | B2 |
9241858 | Hyde et al. | Jan 2016 | B2 |
9246336 | Kurs et al. | Jan 2016 | B2 |
9259369 | Derenne et al. | Feb 2016 | B2 |
9270134 | Gaddam et al. | Feb 2016 | B2 |
9278036 | Lee | Mar 2016 | B2 |
9281701 | Large et al. | Mar 2016 | B2 |
9286441 | Zerhusen et al. | Mar 2016 | B2 |
9289336 | Lambarth et al. | Mar 2016 | B2 |
9295849 | Elghazzawi et al. | Mar 2016 | B2 |
9306322 | Bhimavarapu et al. | Apr 2016 | B2 |
9308303 | Badstibner et al. | Apr 2016 | B2 |
9314105 | Ralws-Meehan | Apr 2016 | B2 |
9314928 | Hyde et al. | Apr 2016 | B2 |
9314929 | Hyde et al. | Apr 2016 | B2 |
9333136 | Gibson et al. | May 2016 | B2 |
9336672 | Collins, Jr. et al. | May 2016 | B2 |
9364625 | Silver et al. | Jun 2016 | B2 |
9369182 | Kurs et al. | Jun 2016 | B2 |
9375374 | Herman et al. | Jun 2016 | B2 |
9381125 | Herbst et al. | Jul 2016 | B2 |
9392875 | Weyl | Jul 2016 | B2 |
9397518 | Theobald | Jul 2016 | B1 |
9407110 | Lui et al. | Aug 2016 | B2 |
9425640 | Moran | Aug 2016 | B2 |
9427367 | White et al. | Aug 2016 | B2 |
9433546 | Rawls-Meehan et al. | Sep 2016 | B2 |
9444520 | Hall et al. | Sep 2016 | B2 |
9451833 | Rawls-Meehan | Sep 2016 | B2 |
9456939 | Lambarth et al. | Oct 2016 | B2 |
9463126 | Zerhusen et al. | Oct 2016 | B2 |
9463324 | Olson et al. | Oct 2016 | B2 |
9465915 | McNeely et al. | Oct 2016 | B2 |
9492339 | Leib | Nov 2016 | B2 |
9496719 | Kesler et al. | Nov 2016 | B2 |
9513899 | Collins, Jr. et al. | Dec 2016 | B2 |
9515494 | Kurs et al. | Dec 2016 | B2 |
9515495 | Kurs et al. | Dec 2016 | B2 |
9517034 | Collins, Jr. et al. | Dec 2016 | B2 |
9526346 | Rawls-Meehan | Dec 2016 | B2 |
9526665 | Rawls-Meehan et al. | Dec 2016 | B2 |
9527699 | Liljedahl | Dec 2016 | B2 |
9537344 | Thompson et al. | Jan 2017 | B2 |
9560787 | Kallmyer et al. | Jan 2017 | B2 |
9577436 | Kesler et al. | Feb 2017 | B2 |
9584189 | Kurs et al. | Feb 2017 | B2 |
9596005 | Kurs et al. | Mar 2017 | B2 |
9601261 | Schatz et al. | Mar 2017 | B2 |
9601270 | Kurs et al. | Mar 2017 | B2 |
9615983 | Stryker et al. | Apr 2017 | B2 |
9734293 | Collins, Jr. et al. | Aug 2017 | B2 |
9768645 | Tetu et al. | Sep 2017 | B2 |
10004651 | DeLuca et al. | Jun 2018 | B2 |
20030079923 | Johnson | May 2003 | A1 |
20040083394 | Brebner et al. | Apr 2004 | A1 |
20050155149 | Pedersen | Jul 2005 | A1 |
20050212478 | Takenaka | Sep 2005 | A1 |
20060059623 | Karmer et al. | Mar 2006 | A1 |
20060108977 | Kagermeier et al. | May 2006 | A1 |
20060249320 | Carter et al. | Nov 2006 | A1 |
20070211866 | Sink | Sep 2007 | A1 |
20070219950 | Crawford | Sep 2007 | A1 |
20070299473 | Matos | Dec 2007 | A1 |
20080041282 | Goschy et al. | Feb 2008 | A1 |
20080086817 | Zucker et al. | Apr 2008 | A1 |
20080295595 | Tacklind et al. | Dec 2008 | A1 |
20090121660 | Rawls-Meehan | May 2009 | A1 |
20100045146 | Thorne | Feb 2010 | A1 |
20100162488 | Dahlin | Jul 2010 | A1 |
20100277121 | Hall et al. | Nov 2010 | A1 |
20100314946 | Budde et al. | Dec 2010 | A1 |
20100328044 | Waffenschmidt et al. | Dec 2010 | A1 |
20110011878 | Baer et al. | Jan 2011 | A1 |
20110030142 | Karwal | Feb 2011 | A1 |
20110043049 | Karalis et al. | Feb 2011 | A1 |
20110117529 | Barash et al. | May 2011 | A1 |
20110162067 | Shuart et al. | Jun 2011 | A1 |
20110208074 | Anderson | Aug 2011 | A1 |
20110247134 | Howell et al. | Oct 2011 | A1 |
20110247137 | Herman et al. | Oct 2011 | A1 |
20110278948 | Forsell | Nov 2011 | A1 |
20110298420 | Forsberg et al. | Dec 2011 | A1 |
20120056729 | Rawls-Meehan | Mar 2012 | A1 |
20120057685 | Rawls-Meehan | Mar 2012 | A1 |
20120069961 | Pomper et al. | Mar 2012 | A1 |
20120084920 | Zucker et al. | Apr 2012 | A1 |
20120086284 | Capanella et al. | Apr 2012 | A1 |
20120091794 | Campanella et al. | Apr 2012 | A1 |
20120091796 | Kesler et al. | Apr 2012 | A1 |
20120091797 | Kesler et al. | Apr 2012 | A1 |
20120091819 | Kulikowski et al. | Apr 2012 | A1 |
20120091820 | Campanella et al. | Apr 2012 | A1 |
20120091949 | Campanella et al. | Apr 2012 | A1 |
20120110738 | Rawls-Meehan | May 2012 | A1 |
20120110824 | Smith et al. | May 2012 | A1 |
20120112536 | Karalis et al. | May 2012 | A1 |
20120112538 | Kesler et al. | May 2012 | A1 |
20120112691 | Kurs et al. | May 2012 | A1 |
20120117730 | Lemire et al. | May 2012 | A1 |
20120119569 | Karalis et al. | May 2012 | A1 |
20120119698 | Karalis et al. | May 2012 | A1 |
20120123242 | Stilley et al. | May 2012 | A1 |
20120139355 | Ganem et al. | Jun 2012 | A1 |
20120228952 | Hall et al. | Sep 2012 | A1 |
20120235501 | Kesler et al. | Sep 2012 | A1 |
20120235502 | Kesler et al. | Sep 2012 | A1 |
20120235504 | Kesler et al. | Sep 2012 | A1 |
20120235566 | Karalis et al. | Sep 2012 | A1 |
20120242159 | Lou et al. | Sep 2012 | A1 |
20120248886 | Kesler et al. | Oct 2012 | A1 |
20120248887 | Kesler et al. | Oct 2012 | A1 |
20120248888 | Kesler et al. | Oct 2012 | A1 |
20120248981 | Karalis et al. | Oct 2012 | A1 |
20120312196 | Newkirk | Dec 2012 | A1 |
20130106347 | Kallmyer et al. | May 2013 | A1 |
20130109973 | Kurokawa | May 2013 | A1 |
20130191992 | Rawls-Meehan | Aug 2013 | A1 |
20140004814 | Elghazzawi | Jan 2014 | A1 |
20140031883 | Elghazzawi | Jan 2014 | A1 |
20140039351 | Mix et al. | Feb 2014 | A1 |
20140045367 | Christie et al. | Feb 2014 | A1 |
20140057235 | Kellum et al. | Feb 2014 | A1 |
20140090173 | DiMaio et al. | Apr 2014 | A1 |
20140139405 | Ribble et al. | May 2014 | A1 |
20140145915 | Ribble et al. | May 2014 | A1 |
20140195057 | Zerhusen et al. | Jul 2014 | A1 |
20140259414 | Hayes et al. | Sep 2014 | A1 |
20140285016 | Tetu et al. | Sep 2014 | A1 |
20140312706 | Fiorello et al. | Oct 2014 | A1 |
20140312707 | Fiorello et al. | Oct 2014 | A1 |
20140327320 | Muhs et al. | Nov 2014 | A1 |
20140343968 | Wilson et al. | Nov 2014 | A1 |
20150069831 | Kesler et al. | Mar 2015 | A1 |
20150075575 | Karlovich | Mar 2015 | A1 |
20150088129 | Ganem et al. | Mar 2015 | A1 |
20150107020 | Andersson et al. | Apr 2015 | A1 |
20150115638 | Lambarth et al. | Apr 2015 | A1 |
20150123484 | Kurs et al. | May 2015 | A1 |
20150128353 | Kildey | May 2015 | A1 |
20150128354 | Greenstein et al. | May 2015 | A1 |
20150130412 | Partovi | May 2015 | A1 |
20150130586 | Rawls-Meehan | May 2015 | A1 |
20150135436 | Stryker et al. | May 2015 | A1 |
20150207351 | Hamburgen et al. | Jul 2015 | A1 |
20150216749 | Heil et al. | Aug 2015 | A1 |
20150251322 | Goodwin et al. | Sep 2015 | A1 |
20150252940 | Goodwin et al. | Sep 2015 | A1 |
20150255994 | Kesler et al. | Sep 2015 | A1 |
20150290061 | Stafford et al. | Oct 2015 | A1 |
20150296550 | Shelly et al. | Oct 2015 | A1 |
20150297427 | Lambarth et al. | Oct 2015 | A1 |
20150297439 | Karlovich | Oct 2015 | A1 |
20150335506 | Kildey | Nov 2015 | A9 |
20150342806 | Hyde et al. | Dec 2015 | A1 |
20150351981 | Sazonov | Dec 2015 | A1 |
20150351982 | Krenik | Dec 2015 | A1 |
20150357831 | Fiorello et al. | Dec 2015 | A1 |
20150360708 | Benton | Dec 2015 | A1 |
20150362333 | Miller et al. | Dec 2015 | A1 |
20150365138 | Miller et al. | Dec 2015 | A1 |
20160000622 | Rawls-Meehan | Jan 2016 | A1 |
20160013837 | Howell | Jan 2016 | A1 |
20160022218 | Hayes et al. | Jan 2016 | A1 |
20160028243 | Schatz et al. | Jan 2016 | A1 |
20160043571 | Kesler et al. | Feb 2016 | A1 |
20160052129 | Ekas | Feb 2016 | A1 |
20160052137 | Hyde et al. | Feb 2016 | A1 |
20160052138 | Hyde et al. | Feb 2016 | A1 |
20160052139 | Hyde et al. | Feb 2016 | A1 |
20160067396 | Stark et al. | Mar 2016 | A1 |
20160070267 | Hyde et al. | Mar 2016 | A1 |
20160075177 | Biderman et al. | Mar 2016 | A1 |
20160089283 | DeLuca et al. | Mar 2016 | A1 |
20160117450 | Zerhusen et al. | Apr 2016 | A1 |
20160120722 | Mueller | May 2016 | A1 |
20160120740 | Rawls-Meehan | May 2016 | A1 |
20160128468 | Lafleche et al. | May 2016 | A1 |
20160136018 | DeLuca et al. | May 2016 | A1 |
20160149425 | Hsu | May 2016 | A1 |
20160158082 | Gainor et al. | Jun 2016 | A1 |
20160158083 | Lambarth et al. | Jun 2016 | A1 |
20160175602 | Aoyama et al. | Jun 2016 | A1 |
20160193397 | Aber et al. | Jul 2016 | A9 |
20160199983 | Hyde et al. | Jul 2016 | A1 |
20160211695 | Singer | Jul 2016 | A1 |
20160213537 | Hayes et al. | Jul 2016 | A1 |
20160242558 | Rawls-Meehan et al. | Aug 2016 | A1 |
20160242681 | Shen et al. | Aug 2016 | A1 |
20160256080 | Shen et al. | Sep 2016 | A1 |
20160275776 | Shen et al. | Sep 2016 | A1 |
20160301253 | Kurs et al. | Oct 2016 | A1 |
20160306762 | Lee et al. | Oct 2016 | A1 |
20160330402 | Benetti | Nov 2016 | A1 |
20160336812 | Fiorello et al. | Nov 2016 | A1 |
20160338891 | Agdeppa et al. | Nov 2016 | A1 |
20160362015 | Fiorello et al. | Dec 2016 | A1 |
20160367415 | Hayes | Dec 2016 | A1 |
20160367420 | Zerhusen et al. | Dec 2016 | A1 |
20160374884 | Blickensderfer et al. | Dec 2016 | A1 |
20170011181 | McNeely et al. | Jan 2017 | A1 |
20170015376 | Belman | Jan 2017 | A1 |
20170020440 | Flitsch et al. | Jan 2017 | A1 |
20170027789 | St.John et al. | Feb 2017 | A1 |
20170035295 | Collins, Jr. et al. | Feb 2017 | A1 |
20170035370 | Collins, Jr. et al. | Feb 2017 | A1 |
20170047762 | Tuseth et al. | Feb 2017 | A1 |
20170053736 | Hall et al. | Feb 2017 | A9 |
20170053737 | Kurs | Feb 2017 | A1 |
20170054319 | Kesler et al. | Feb 2017 | A1 |
20170055882 | Al-Ali et al. | Mar 2017 | A1 |
20170055887 | Al-Ali | Mar 2017 | A1 |
20170062124 | Hall et al. | Mar 2017 | A9 |
20170063143 | Hoarau et al. | Mar 2017 | A1 |
20170065766 | Olson et al. | Mar 2017 | A1 |
20170098044 | Lai et al. | Apr 2017 | A1 |
20170119607 | Derenne et al. | May 2017 | A1 |
20170158329 | Liu | Jun 2017 | A1 |
20170259811 | Coulter | Sep 2017 | A1 |
20170281440 | Puvogel et al. | Oct 2017 | A1 |
20170337797 | McClellan | Nov 2017 | A1 |
20170340498 | Tessmer | Nov 2017 | A1 |
20180056985 | Coulter | Mar 2018 | A1 |
20180228676 | Merdek | Aug 2018 | A1 |
20190046373 | Coulter | Feb 2019 | A1 |
20190123587 | Titov | Apr 2019 | A1 |
20190231160 | Lu | Aug 2019 | A1 |
Number | Date | Country |
---|---|---|
2008316723 | Apr 2009 | AU |
2187727 | Apr 1997 | CA |
104097531 | Oct 2014 | CN |
0315210 | Jul 1994 | EP |
0700574 | Jul 1997 | EP |
8903665 | May 1989 | WO |
9100054 | Jan 1991 | WO |
9428560 | Dec 1994 | WO |
9620754 | Jul 1996 | WO |
2004038890 | May 2004 | WO |
2005016216 | Feb 2005 | WO |
2005077102 | Aug 2005 | WO |
2007063500 | Jun 2007 | WO |
2007064609 | Jun 2007 | WO |
2007118221 | Oct 2007 | WO |
2007136733 | Nov 2007 | WO |
2008003027 | Jan 2008 | WO |
2008036087 | Mar 2008 | WO |
2008050260 | May 2008 | WO |
2008050292 | May 2008 | WO |
2008055664 | May 2008 | WO |
2008150448 | Dec 2008 | WO |
2009009296 | Mar 2009 | WO |
2009055203 | Apr 2009 | WO |
2009055432 | Apr 2009 | WO |
2009120970 | Oct 2009 | WO |
2009123780 | Oct 2009 | WO |
2009135081 | Nov 2009 | WO |
2010027282 | Mar 2010 | WO |
2010036980 | Apr 2010 | WO |
2010059096 | May 2010 | WO |
2010059097 | May 2010 | WO |
2010093997 | Aug 2010 | WO |
2011096111 | Aug 2011 | WO |
2011113070 | Sep 2011 | WO |
2011156768 | Dec 2011 | WO |
2012087807 | Jun 2012 | WO |
2012100219 | Jul 2012 | WO |
2012122002 | Sep 2012 | WO |
2012135118 | Oct 2012 | WO |
2012170278 | Dec 2012 | WO |
2013006845 | Jan 2013 | WO |
2013009881 | Jan 2013 | WO |
2013049979 | Apr 2013 | WO |
2013050699 | Apr 2013 | WO |
2013044165 | May 2013 | WO |
2013062808 | May 2013 | WO |
2013062809 | May 2013 | WO |
2013072306 | May 2013 | WO |
2013074452 | May 2013 | WO |
2013078092 | May 2013 | WO |
2013112782 | Aug 2013 | WO |
2013123119 | Aug 2013 | WO |
2013131078 | Sep 2013 | WO |
2013142840 | Sep 2013 | WO |
2013156907 | Oct 2013 | WO |
2013158675 | Oct 2013 | WO |
2014014581 | Jan 2014 | WO |
2014043659 | Mar 2014 | WO |
2014046844 | Mar 2014 | WO |
2014052147 | Apr 2014 | WO |
2014052148 | Apr 2014 | WO |
2014078667 | May 2014 | WO |
2014097055 | Jun 2014 | WO |
2014113164 | Jul 2014 | WO |
2014150970 | Sep 2014 | WO |
2014151577 | Sep 2014 | WO |
2014164248 | Oct 2014 | WO |
2015010702 | Jan 2015 | WO |
2015106239 | Jul 2015 | WO |
2015108653 | Jul 2015 | WO |
2015148578 | Oct 2015 | WO |
2015191819 | Dec 2015 | WO |
2016090384 | Jun 2016 | WO |
2016167594 | Oct 2016 | WO |
2016179562 | Nov 2016 | WO |
2017025735 | Feb 2017 | WO |
2017040317 | Mar 2017 | WO |
Entry |
---|
Colson Group USA, “EZ Wheel Brochure”, 2017, 4 pages. |
Daily Mail Reporter, “Move over Fred Flintstone: The human-powered car that can reach speeds of up to 60mph”, http://www.dailymail.co.uk/motoring/article-1304120/The-human-powered-car-reach-speeds-60mph.html, Aug. 19, 2010, 5 Pages. |
English language abstract and machine-assisted English translation for CN 104097531 extracted from espacenet.com database on Jan. 10, 2019, 6 pages. |
English language abstract and machine-assisted English translation for WO 2013/072306 extracted from espacenet.com database on Jan. 10, 2019, 14 pages. |
English language abstract and machine-assisted English translation for WO 91/00054 extracted from espacenet.com database on Jan. 14, 2019, 11 pages. |
English language abstract for WO 2008/055664 extracted from espacenet.com database on Jan. 14, 2019, 2 pages. |
English language abstract for WO 2011/096111 and machine-assisted English translation for CN 102812617, an equivalent of WO 2011/096111, extracted from espacenet.com database on Jan. 10, 2019, 22 pages. |
English language abstract for WO 2013/049979 extracted from espacenet.com database on Jan. 10, 2019, 1 page. |
English language abstract for WO 2013/050699 extracted from espacenet.com database on Jan. 14, 2019, 1 page. |
English language abstract not found for AU 2008316723; however, see English language equivalent U.S. Pat. No. 9,734,293. Original document extracted from espacenet.com databasse on Jan. 10, 2019, 1 page. |
EZ-Wheel, “La Premiere Roue Electrique Autonome-Integrant Moteur and Batteries Brochure”, http://www.ez-wheel.com, 2017, 8 pages. |
Stryker SA, “Prime TC Transport Chair Brochure”, 2013, 8 pages. |
U.S. Appl. No. 16/168,089, filed Oct. 23, 2018. |
YOUTUBE “Tesla Charging Snake Video”, Aug. 6, 2015, https://www.youtube.com/watch?v=ut3sELMOyTM, 3 pages. |
Number | Date | Country | |
---|---|---|---|
20190117487 A1 | Apr 2019 | US |
Number | Date | Country | |
---|---|---|---|
62576318 | Oct 2017 | US |